Xenon Pharmaceuticals (XENE) Change in Receivables (2013 - 2025)
Xenon Pharmaceuticals (XENE) posted quarterly Change in Receivables of $7.2 million for Q1 2025, up 18989.47% year-over-year from N/an in Q1 2024, and up 1212.25% quarter-over-quarter from $547000.0 in Q4 2024.
Xenon Pharmaceuticals (XENE) Change in Receivables (2013 - 2025) Analysis & Trends
Xenon Pharmaceuticals (XENE) has reported Change in Receivables for 13 consecutive years, with $7.2 million the latest figure, recorded in Q1 2025.
- In Q1 2025, Change in Receivables rose 18989.47% year-over-year to $7.2 million; the TTM figure through Mar 2025 stood at $7.8 million (up 13400.0% YoY), while the FY2024 annual figure was $614000.0, up 572.31% from the prior year.
- Change in Receivables advanced to $7.2 million in Q1 2025 per XENE's latest filing, from $547000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $7.2 million in Q1 2025 and bottomed at -$2.6 million in Q2 2021.
- Historically, Change in Receivables has averaged $374352.9 across 5 years, with a median of -$7000.0 in 2022.
- Annual changes were most pronounced in 2023 — Change in Receivables slumped 2114.29% — and 2025, when it soared 18989.47%.
- Xenon Pharmaceuticals' Change in Receivables stood at -$481000.0 in 2021, then slumped by 214.97% to -$1.5 million in 2022, then soared by 119.41% to $294000.0 in 2023, then surged by 86.05% to $547000.0 in 2024, then jumped by 1212.25% to $7.2 million in 2025.
- Business Quant data shows XENE's Change in Receivables at $7.2 million in Q1 2025, $547000.0 in Q4 2024, and $83000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Xenon Pharmaceuticals | 6.03 Bn | 6.03 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 7.18 Mn |
| Mar 31, 2025 | 7.18 Mn |
| Dec 31, 2024 | 547,000.00 |
| Dec 31, 2024 | 547,000.00 |
| Sep 30, 2024 | 83,000.00 |
| Sep 30, 2024 | 83,000.00 |
| Jun 30, 2024 | 22,000.00 |
| Jun 30, 2024 | 22,000.00 |
| Mar 31, 2024 | -38,000.00 |
| Mar 31, 2024 | -38,000.00 |
| Dec 31, 2023 | 294,000.00 |
| Dec 31, 2023 | 294,000.00 |
| Sep 30, 2023 | -155,000.00 |
| Sep 30, 2023 | -155,000.00 |
| Jun 30, 2023 | -43,000.00 |
| Jun 30, 2023 | -43,000.00 |
| Mar 31, 2023 | -226,000.00 |
| Mar 31, 2023 | -226,000.00 |
| Dec 31, 2022 | -1.52 Mn |
| Dec 31, 2022 | -1.52 Mn |